Chinawa J M, Emodi I J, Ikefuna A N, Ocheni S
Department of Paediatrics, University of Nigeria Enugu Campus Enugu, Nigeria.
Niger J Clin Pract. 2013 Apr-Jun;16(2):159-63. doi: 10.4103/1119-3077.110132.
Sickle cell anemia is associated with a hypercoagulable state that may lead to alterations in a coagulation profile. Measurements of coagulation factors are known to have some predictive value for clinical outcome.
To determine the coagulation profile of children with SCA in steady state and crisis and compare it with those with normal HbAA genotype.
This is a prospective observational study involving 50 children with SCA in steady state, 50 in crises, and 50 with HbAA genotype, carried out from June to October 2009. All the values of coagulation profile were matched for age and sex.
The mean Prothrombin time (PT) (12.5 ± 1.2 secs), Activated partial thromboplastin time (aPTT) (41.6 ± 1.0 secs), and Thrombin time (TT) (12.3 ± 1.2 secs) of subjects with SCA in steady state as well as those during crises [PT (12.6 ± 1.8 secs), aPTT (45.6 ± 1.3 secs), TT (12.5 ± 1.7 secs)] were significantly prolonged compared to those of subjects with HbAA genotype. The mean bleeding time (BT) of 3.4 ± 1.0 mins was significantly shorter in children with SCA in steady state compared to those with HbAA genotype (3.7 ± 1.1 mins), (P < 0.038).
Coagulation profile of patients with SCA is prolonged both in steady state and during crisis and when compared to those with HbAA genotype, though all values are within normal range.
镰状细胞贫血与高凝状态相关,可能导致凝血指标改变。已知凝血因子测量对临床结局有一定预测价值。
确定稳态和危象期镰状细胞贫血患儿的凝血指标,并与正常HbAA基因型患儿进行比较。
这是一项前瞻性观察性研究,于2009年6月至10月进行,纳入50例稳态期镰状细胞贫血患儿、50例危象期患儿以及50例HbAA基因型患儿。所有凝血指标值均按年龄和性别进行匹配。
稳态期以及危象期镰状细胞贫血患儿的平均凝血酶原时间(PT)[稳态期:(12.5 ± 1.2秒),危象期:(12.6 ± 1.8秒)]、活化部分凝血活酶时间(aPTT)[稳态期:(41.6 ± 1.0秒),危象期:(45.6 ± 1.3秒)]和凝血酶时间(TT)[稳态期:(12.3 ± 1.2秒),危象期:(12.5 ± 1.7秒)]与HbAA基因型患儿相比均显著延长。稳态期镰状细胞贫血患儿的平均出血时间(BT)为3.4 ± 1.0分钟,显著短于HbAA基因型患儿(3.7 ± 1.1分钟),(P < 0.038)。
镰状细胞贫血患者在稳态期和危象期的凝血指标均延长,与HbAA基因型患者相比也是如此,尽管所有指标值均在正常范围内。